-
Ortho Evra Lawsuits May Get MDL Status in Federal Court System
Birth Control Patch Allegedly Causes Serious Cardiovascular Problems Late in 2005, a motion was filed with the Judicial Panel on Multidistrict Litigation (JPML) by a plaintiff’s lawyer requesting the consolidation of all federal court…
-
FDA Warns MS Patients Not to Use Leukemia Drug Campath
Reports of Severe Blood Disorder ITP In 3 Campath – MS Study Patients On November 30, 2005 the FDA issued a public health advisory warning against the use of Campath in patients with multiple…
-
Eric Topol’s Deposition Testimony Allowed At First Federal Vioxx Trial
Judge Fallon Ruling: Jury Will Hear And See Dr. Topol Criticize Merck In Video Deposition At Irvin / Plunkett Trial On November 30, 2005 The Wall Street Journal (WSJ) reported that the jury in…
-
Next Set of Vioxx Trials in New Jersey Assigned Court Dates By Judge Higbee
New Jersey Judge Sets A February 27, 2006 Trial Date for Next NJ Vioxx Case In late November 2005 New Jersey Superior Court Judge Carol Higbee announced that she tentatively plans to consolidate the…
-
Irvin / Plunkett v. Merck: Federal Court MDL Vioxx Trial Starts in Texas
AP Reports At Least 7,875 Vioxx Lawsuits Filed By Thanksgiving Day 2005 The first Vioxx federal trial, Irvin / Plunkett v. Merck, is scheduled to start today, November 29, 2005, in Houston, Texas. This…
-
Study On Cardiovascular Safety of Celebrex Reported at 2005 ACR Meeting
No Increased Risk Of Heart Attack Or Stroke For Patients Taking Celebrex According to a meta-analysis reported by Dr. Lee Simon, Associate Clinical Professor of Medicine at Harvard Medical School, the COX-2 specific…
